A Double-blind Study of KRN321 for the Treatment of Anemia in Cancer Patients

PHASE3CompletedINTERVENTIONAL

Enrollment

200

Participants

Timeline

Start Date

March 31, 2006

Primary Completion Date

May 31, 2007

Conditions

Anemia

Interventions

DRUG

darbepoetin alfa

Trial Locations (7)

Shikoku region, Ehime

Kyusyu region, Fukuoka, Kagoshima

Chugoku region, Hiroshima, Tottori

Tohoku region, Iwate, Miyagi

Kinki region, Nara, Osaka, Hyogo

Tokai region, Shizuoka, Aichi

Kanto region, Tokyo, Chiba, Ibaraki, Saitama, Niigata

All Listed Sponsors

lead

Kyowa Kirin Co., Ltd.

INDUSTRY

NCT00344409 - A Double-blind Study of KRN321 for the Treatment of Anemia in Cancer Patients | Biotech Hunter | Biotech Hunter